Sign in
Not yet recruitingPhase 2

Nanofat injections for osteoarthritis of the jaw joint

Tests nanofat injected into the jaw joint of adults with osteoarthritis.

Key facts

Who runs it
Tartu University Hospital
Where
Estonia1 site in 1 countryChoose a country to see its sites
Registry title
The usage of unenriched emulsified fat transplant in temporomandibular joint degenerative diseases
Status
Not yet recruiting
Phase
Phase 2
People taking part
14 people, planned
Started
1 Sept 2022
Planned end
31 May 2026
Type of study
Interventional
Record updated
12 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with wear-and-tear arthritis of the jaw joint (TMJ OA). It tests injections of the person's own processed fat (nanofat) into the joint.

Age
18-65 years in the criteria; the record's age fields say 18 Years to 64 Years.
Sex
All sexes can join.
Disease stage
Jaw joint osteoarthritis at stage 4 or 5 on the Wilkes classification.
Earlier treatment
At least 6 months of non-surgical (conservative) treatment that did not help. People who had surgery on the jaw joint before cannot join.

Main reasons for not taking part

  • Pregnancy
  • Cancer or lymphoproliferative disorders (cancers of the lymph system)
  • Blood clotting disorders or diabetes
  • Acute viral infections or other severe chronic or general health conditions
  • Prior surgery on the jaw joint

The registry criteria, word for word

Show the criterionShow less

Who can take part

  • The study plans to include patients aged 18-65 years, with TMJ OA classified as stage 4 or 5 according to the Wilkes classification (9), and who have not responded to at least 6 months of conservative treatment. Participation in the study is voluntary, and the participant may withdraw at any stage

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to determine the effectiveness of using nanofat in the treatment of temporomandibular joint osteoarthritis (TMJ OA). The study seeks to identify correlations between the patient's subjective symptoms, clinical presentation, and radiological findings, perform data analysis, and apply the results in clinical practice.

Read full original descriptionShow less

The hypothesis of this study is that the injection of autologous nanofat into the temporomandibular joint slows the progression of degenerative changes, promotes the regeneration of the deformed joint surface, and thereby improves the quality of life for patients.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
The usage of unenriched emulsified fat transplant in temporomandibular joint degenerative diseases
Plain-language title
Nanofat injections for osteoarthritis of the jaw jointGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from 2024-520244-41-00, who can take part
Record updated
12 March 2025